Genteric , Inc.

Industry:	Pharmaceuticals, Biotechnology, Drug Manufacturing & Research
Revenues:	Under $20 Million

Description

About Genteric, Inc. Genteric is a biotech company formed to commercialize several proprietary technology platforms that harness the body's own protein production and distribution system. Using improved, non-viral and viral gene delivery techniques, Genteric's unique approach converts genes into therapeutic proteins within the patient's salivary glands and other gastrointestinal organs. This system then distributes the therapeutic proteins to blood, using the network nature designed for that purpose. The Genteric Method will permit the in vivo production and distribution of therapeutic quantities of virtually any desired protein.

News Archive

CNS Protein Therapeutics Changes Its Name and Elects New CEO. Health & Beauty Close-Up; 11/3/2009 ...BioTherapeutics, Inc., a vaccine company that he founded in 2003. Previously, Cleary was President, CEO & Director of Genteric, Inc; President, CEO & Co-founder of CardioGene Therapeutics; President, CEO & Co-founder of Theragen... ...more

CNS Protein Therapeutics Completes Name Change to Amarantus Therapeutics, Appoints New CEO Martin D. Cleary. Heart Disease Weekly; 11/15/2009 ...BioTherapeutics, Inc., a vaccine company that he founded in 2003. Previously, Mr. Cleary was President, CEO & Director of Genteric, Inc; President, CEO & Co-founder of CardioGene Therapeutics; President, CEO & Co-founder of Theragen... ...more